PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination

Bayer44,920 enrolled

Overview

The purpose of this study is to obtain data on the safety and efficacy of Ultravist application in usual daily use.The radiologist will administer the contrast medium to the patient as he/she would have done without the study. No other examinations will be performed than would have been done routinely.

Study Type

OBSERVATIONAL

Enrollment

44,920

Conditions

Diagnostic Imaging

Interventions

Ultravist (Iopromide, BAY86-4877)DRUG

Patients with indication for an X-ray examination and for whom the radiologist has decided to use the contrast medium Ultravist.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with indication for an X-ray examination and for whom the radiologist has decided to use the contrast medium Ultravist. Exclusion Criteria: * No exclusion criteria besides the contraindications for the use of Ultravist as mentioned in the product information.

Locations (21)

Unnamed facility

Many Locations, Bosnia and Herzegovina

Unnamed facility

Many Locations, China

Unnamed facility

Many Locations, Germany

Outcomes

Primary Outcomes

Occurrence of adverse events

Time frame: During and after Ultravist application on the day of examination

Secondary Outcomes

General contrast quality in the region of interest as assessed by physicians

Time frame: On the day of examination

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.